Improving Diversity In Clinical Trials
![21_03_LSL_DiversityClinicalTrials_ebook_450x300 21_03_LSL_DiversityClinicalTrials_ebook_450x300](https://vertassets.blob.core.windows.net/image/5f904ca3/5f904ca3-b8c1-464f-8dc4-330f97d9344f/375_250-21_03_lsl_diversityclinicaltrials_ebook_450x300.png)
The lack of diversity in clinical trials isn’t a new problem, but in 2020 this issue rose to the forefront of the industry as a spotlight was cast on drug development as a whole due to the COVID pandemic. In fact, a key milestone related to this topic came in November 2020 when the FDA issued its final guidance, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs. The experts in this ebook come from varying backgrounds, and as such, offer a myriad of recommendations relating to improving clinical trial enrollment of racial and ethnic minority groups.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.